New Research on Aspirin and Cancer Prevention
New research is revealing potential ways in which aspirin could help prevent certain cancers from developing or spreading, according to recent findings.
Trial Evidence Grows
Long-term studies are increasingly supporting the idea that aspirin may reduce the risk of some cancers, especially bowel cancer. According to reports, clinical trials involving individuals with Lynch syndrome—a genetic condition that increases cancer risk—have shown promising results.
Professor John Burn, who led one major study, highlighted that patients taking aspirin for two years experienced significant benefits over time. “The people who took aspirin for two years had 50% fewer cancers in the colon,” he stated.
Real-World Impact
One participant, Nick James, joined the trial after discovering he carried the gene linked to Lynch syndrome. According to reports, he has now taken aspirin for a decade without developing cancer, despite his high personal risk.
The findings have already influenced medical guidelines, with some countries recommending low-dose aspirin for high-risk groups under medical supervision. The BBC reported that Sweden has introduced screening and treatment changes based on similar research.
How It Works
Scientists are beginning to understand why aspirin appears to have this protective effect. “This fantastic drug works both within the cell and outside the cell,” said Professor Anna Martling. According to reports, aspirin blocks enzymes such as Cox-2, which are linked to processes that can trigger uncontrolled cell growth.
Other research suggests it may also help the immune system detect and attack cancer cells more effectively.
Wider Research Underway
Researchers are now investigating whether the benefits extend beyond bowel cancer. According to reports, a major international trial involving 11,000 participants is examining aspirin’s effects on several cancer types.
“We really are the first to explore the role of aspirin in other tumour types,” said Professor Ruth Langley. The results of these studies could shape future treatment guidelines.
Caution Remains
Despite promising findings, experts warn that aspirin is not suitable for everyone. According to reports, side effects can include bleeding and stomach issues, meaning its use must be carefully managed.
“Always speak to a doctor or other healthcare professional before starting aspirin,” Langley said. While the drug’s potential continues to emerge, researchers say more evidence is needed before wider recommendations can be made.
